EyePoint Pharmaceuticals
American pharmaceuticals company
From Wikipedia, the free encyclopedia
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
| Formerly | pSivida Corp. |
|---|---|
| Type | Public company |
| Nasdaq: EYPT ASX: PVA FWB: PV3 | |
| Industry | Pharmaceuticals |
| Headquarters | , |
Number of locations | 2 |
| Products | Iluvien |
| Website | www |
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ).[citation needed] QinetiQ continues to be a strategic partner.[1][2]
In June 2004, pSivida acquired full ownership of pSiMedica.[1] In April 2018, pSivida purchased eye products firm Icon Bioscience.[3][4] Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.[5]
See also
- Alimera Sciences, pSvida's partner on Iluvien
